-
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives Consensus Rating of "Moderate Buy" from Brokerages
Source: Buzz FX / 04 Mar 2025 04:21:15 America/New_York
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives Consensus Rating of "Moderate Buy" from Brokerages Written by MarketBeat March 4, 2025 Share Link copied to clipboard. Collegium Pharmaceutical, Inc.
Read more...